On univariate analysis, no predictors were significantly associated with LPFS, but CTV (continuous; P = .051; hazard ratio [HR]: 1.050; 95% CI, 1.000-1.103) and neoadjuvant chemotherapy ( P = .071; HR: 0.129; 95% CI, 0.014-1.196) demonstrated a trend toward significance ( Table 2 ).
← all excerpts
Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins.
1
—
—